Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 103,862 | 108,809 | 96,327 | 113,844 | 100,466 |
| Cost of Goods | 34,346 | 34,366 | 31,703 | 38,605 | 31,164 |
| Gross Profit | 69,516 | 74,443 | 64,624 | 75,239 | 69,302 |
| Operating Expenses | 95,421 | 100,448 | 101,650 | 95,202 | -12,616 |
| Operating Income | -25,559 | -25,639 | -36,323 | -19,358 | 82,082 |
| Interest Expense | 1,618 | 1,618 | 1,613 | 1,613 | 1,608 |
| Other Income | 3,828 | 3,010 | 3,232 | 2,135 | 1,519 |
| Pre-tax Income | -23,349 | -24,247 | -34,704 | -18,836 | 81,993 |
| Income Tax | 130 | 477 | 325 | 356 | 485 |
| Net Income Continuous | -23,479 | -24,724 | -35,029 | -19,192 | 81,508 |
| Net Income | $-23,479 | $-24,724 | $-35,029 | $-19,192 | $81,508 |
| EPS Basic Total Ops | -0.65 | -0.69 | -0.98 | -0.53 | 2.30 |
| EPS Basic Continuous Ops | -0.65 | -0.69 | -0.98 | -0.53 | 2.30 |
| EPS Diluted Total Ops | -0.65 | -0.69 | -0.98 | -0.45 | 2.22 |
| EPS Diluted Continuous Ops | -0.65 | -0.69 | -0.98 | -0.41 | 2.18 |
| EPS Diluted Before Non-Recurring Items | -0.65 | -0.69 | -0.98 | N/A | N/A |
| EBITDA(a) | $-23,386 | $-23,437 | $-34,264 | $-16,941 | $85,077 |